cevimeline   Click here for help

GtoPdb Ligand ID: 9658

Synonyms: Evoxac®
Approved drug
cevimeline is an approved drug (FDA (2000))
Compound class: Synthetic organic
Comment: Cevimeline is an orally administered cholinergic analogue with parasympathomimetic activity. The INN is a mixture of enantiomers. We show the structure without stereochemistry to represent the mixture.
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: cevimeline

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 2
Hydrogen bond donors 0
Rotatable bonds 0
Topological polar surface area 37.77
Molecular weight 199.1
XLogP 1.29
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC1SCC2(O1)CN1CCC2CC1
Isomeric SMILES CC1SCC2(O1)CN1CCC2CC1
InChI InChI=1S/C10H17NOS/c1-8-12-10(7-13-8)6-11-4-2-9(10)3-5-11/h8-9H,2-7H2,1H3
InChI Key WUTYZMFRCNBCHQ-UHFFFAOYSA-N
Bioactivity Comments
Bioactivity may be associated with the administered form, cevimeline hydrochloride, and with enantiomers with specified stereochemistry.
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
M2 receptor Hs Agonist Agonist 6.1 pKi - 1
pKi 6.1 (Ki 8.54x10-7 M) [1]
Description: Displacement of [3H]QNB from cloned receptor.
M4 receptor Hs Agonist Agonist 6.0 pKi - 1
pKi 6.0 (Ki 1.012x10-6 M) [1]
Description: Displacement of [3H]QNB from cloned receptor.
M3 receptor Hs Agonist Agonist 5.6 pKi - 1
pKi 5.6 (Ki 2.575x10-6 M) [1]
Description: Displacement of [3H]QNB from cloned receptor.
M1 receptor Hs Agonist Agonist 5.3 pKi - 1
pKi 5.3 (Ki 4.85x10-6 M) [1]
Description: Displacement of [3H]QNB from cloned receptor.